These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18312820)

  • 1. Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice.
    Treloar C; Laybutt B; Jauncey M; van Beek I; Lodge M; Malpas G; Carruthers S
    Int J Drug Policy; 2008 Feb; 19(1):59-65. PubMed ID: 18312820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs.
    Davis M; Rhodes T; Martin A
    Soc Sci Med; 2004 Nov; 59(9):1807-18. PubMed ID: 15312916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S; Glanz J; Barón A
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Jailbreak Health Project--incorporating a unique radio programme for prisoners.
    Minc A; Butler T; Gahan G
    Int J Drug Policy; 2007 Oct; 18(5):444-6. PubMed ID: 17854735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia.
    Rhodes T; Zikic B; Prodanović A; Kuneski E; Bernays S
    Soc Sci Med; 2008 Mar; 66(6):1437-47. PubMed ID: 18201809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study.
    Roux P; Le Gall JM; Debrus M; Protopopescu C; Ndiaye K; Demoulin B; Lions C; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri MP
    Addiction; 2016 Jan; 111(1):94-106. PubMed ID: 26234629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social inclusion and hepatitis C: exploring new possibilities for prevention.
    Treloar C; Valentine K; Fraser S
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):397-404. PubMed ID: 21504397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
    Hopwood M; Treloar C
    Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staying safe from hepatitis C: engaging with multiple priorities.
    Harris M; Treloar C; Maher L
    Qual Health Res; 2012 Jan; 22(1):31-42. PubMed ID: 21873284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre.
    Gustafson DL; Goodyear L; Keough F
    Int J Drug Policy; 2008 Jun; 19(3):189-94. PubMed ID: 18472260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
    Kretzschmar M; Wiessing L
    AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
    Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'It's your life!': injecting drug users, individual responsibility and hepatitis C prevention.
    Fraser S
    Health (London); 2004 Apr; 8(2):199-221. PubMed ID: 15068637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injecting drug users' understanding of hepatitis C.
    O'Brien S; Day C; Black E; Dolan K
    Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of a heroin overdose prevention and education campaign.
    Horyniak D; Higgs P; Lewis J; Winter R; Dietze P; Aitken C
    Drug Alcohol Rev; 2010 Jan; 29(1):5-11. PubMed ID: 20078676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing hepatitis C: what do positive injectors do?
    Carruthers SJ
    Drug Alcohol Rev; 2005 Mar; 24(2):193-8. PubMed ID: 16076589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C in Australia: impact of a mass media campaign.
    Smith BJ; Bauman AE; Chen J; Loveday S; Costello M; Mackie B; Dore GJ
    Am J Prev Med; 2006 Dec; 31(6):492-8. PubMed ID: 17169710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.